Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Investigational site, La Palma

Novartis Investigational Site, Kansas City

Novartis Investigational Site, Shreveport

Novartis Investigational Site, Somerville

Novartis Investigational Site, Farmington Hills

Novartis Investigational Site, Staten Island

Novartis Investigational Site, Madison

Novartis Investigational Site, Bellaire

Novartis Investigational Site, Dallas

Novartis Investigational Site, Verdun

Novartis Investigational Site, Bellevue

Novartis Investigational Site, Kirkland

Novartis Investigational site, West Allis

Novartis Investigational Site, Vienna

Novartis Investigational Site, Greater Sudbury

Novartis Investigational Site, Kelowna

Novartis Investigational Site, London

Novartis Investigational Site, Montreal

Novartis Investigator Site, Vancouver

Novartis Investigational Site, Bogotá

Novartis Investigational Site, Medellín

Novartis Investigational Site, Pareira

Novartis Investigational Site, Brno

Novartis Investigational Site, Hradec Králové

Novartis Investigational Site, Prague

Novartis Investigational Site, Berlin

Novartis Investigational Site, Bochum

Novartis Investigational Site, Dresden

Novartis Investigational Site, Ingolstadt

Novartis Investigational Site, Mannheim

Novartis Investigational Site, Würzburg

Novartis Investigational Site, Guatemala City

Novartis Investigational Site, Lima

Novartis Investigational Site, Moscow

Novartis Investigational Site, Yaroslavl

Novartis Investigational Site, Bojnice

Novartis Investigational Site, Michalovce

Novartis Investigational Site, Durban

Novartis Investigational Site, Dnipro

Novartis Investigational Site, Kiev

Novartis Investigational Site, Luhansk

Novartis Investigational Site, Odesa

Novartis Investigational Site, Simferopol

Novartis Investigational Site, Caracas